Ischemic stroke, intracerebral hemorrhage
Conditions
Interventions
Duration of treatment: In addition to the usual rehabilitation, BMI treatment using a medical BMI device (hand type) will be performed 20 times for 30 days after enrollment. Thereafter, the patient wi
Sponsors
University of Toyama
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria will be included in this study (1) Patients 18 years of age or older (2) Patients within 7 days of stroke (cerebral infarction, cerebral hemorrhage) (3) Patients with upper limb paralysis due to stroke (4) Patients with an FMA-UE (Fugel-Meyer assessment - upper extremity motor score) of less than 20 points and a score of 0 or 1 for group extension in the FMA C item at the time of initial evaluation (5) Patients who have given their written consent to participate in this clinical study.
Exclusion criteria
Exclusion criteria: Patients who meet any of the following criteria will not be included in this study (1) Patients with a pacemaker or implantable cardioverter-defibrillator (2) Patients who were participating in other clinical trials prior to study entry (3) Patients who failed to complete the initial BMI training (4) Patients deemed ineligible by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FMA_UE (Fugel-Meyer assessment - upper extremity motor score) at 56 days after the start of BMI | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) 10-point sensory evaluation 2) MAL (Motor activity log) 3) Upper limb EMG and video evaluation 4) Upper extremity MEP (motor evoked potential) 5) EQ-5D (EuroQol 5-dimensions) 6) Diffusion tensor image (diffusion tensor image; DTI) 7) EEG evaluation during BMI training | — |
Countries
Japan
Contacts
Public ContactSatoshi Kuroda
Toyama University Hospital Neurosurgery
Outcome results
None listed